Month: December 2016

Opsona News 2

Preliminary results in Opsona’s myelodysplastic syndrome study

Dublin, Ireland – Opsona Therapeutics Ltd (‘Opsona’), the innate immune drug development company focused on novel therapeutic approaches to treat oncology, autoimmune and other inflammatory diseases, today announces the preliminary results from its ongoing prospective, open label Phase I/II study being conducted with OPN-305 in second-line lower (Low and intermediate-1) risk myelodysplastic syndrome (MDS) which …

Preliminary results in Opsona’s myelodysplastic syndrome study Read More »

Labcyte News Logo

Labcyte Announces Collaboration with Notable Labs

Sunnyvale, CA, and San Francisco, CA. 7 December 2016.  Labcyte Inc. and Notable Labs today announced a collaboration to apply the unique capabilities of Labcyte’s revolutionary Echo® acoustic liquid handling technology to screen individual cancer patients’ tumor cells.  This functional screening identifies which available drugs or drug combinations may be most effective at treating their …

Labcyte Announces Collaboration with Notable Labs Read More »

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top